These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4799440)

  • 21. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombin activity of blood in experimental extrahepatic cholestasis].
    Burnazian RA; Kiianov VI; Petrishchev NN
    Zh Eksp Klin Med; 1976; 16(2):22-8. PubMed ID: 973498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Plasma antithrombin-III in nephrotic syndrome patients].
    Poliantseva LR; Andreenko GV; Podorol'skaia LV
    Klin Med (Mosk); 1979 Aug; 57(8):38-43. PubMed ID: 502411
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of serum antithrombins for the determination of plasmatic hypercoagulability in acute cardiovascular diseases. II. Normal values of antithrombin capacity and the in vivo effect of anticoagulants and streptokinase in humans and frequently used laboratory animals].
    Duck HJ; Köhler H; Trenckmann H; Fiedler G
    Z Gesamte Inn Med; 1979 Mar; 34(5):133-8. PubMed ID: 463165
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibitory effects of estrogen on antithrombin III (author's transl)].
    Fujimaki M; Nagasawa H; Konishi S; Kato M; Fukutake K
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):227-31. PubMed ID: 196473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of a thrombotic tendency by means of coagulation tests (author's transl)].
    von Kaulla E; von Kaulla KN
    MMW Munch Med Wochenschr; 1974 Aug; 116(31):1387-96. PubMed ID: 4212608
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of low-dose-heparin and its control (author's transl)].
    Zanoni G
    Schweiz Rundsch Med Prax; 1976 Apr; 65(16):477-80. PubMed ID: 981166
    [No Abstract]   [Full Text] [Related]  

  • 29. [The behaviour of physiologic inhibitors of blood coagulation and of the thrombelastogram in pregnancy].
    Tismer R; Egli H; Schander K
    Z Geburtshilfe Perinatol; 1972 Jun; 176(3):193-201. PubMed ID: 5070001
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin 3 and diseases.
    Von Kaulla E; Von Kaulla KN
    Am J Clin Pathol; 1967 Jul; 48(1):69-80. PubMed ID: 5339224
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 34. Human antithrombin concentrates and experimental disseminated intravascular coagulation.
    Mammen EF; Miyakawa T; Phillips TF; Assarian GS; Brown JM; Murano G
    Semin Thromb Hemost; 1985 Oct; 11(4):373-83. PubMed ID: 4071063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of antigenecity of blood clotting factors during the process of blood coagulation (author's transl)].
    Fujimaki M; Iematsu S; Kato M; Kogiso H; Matsubara Y
    Rinsho Byori; 1978; 26(4):298-304. PubMed ID: 671776
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on serum AT III levels in various diseases (author's transl)].
    Yamaguchi T; Konishi M; Kuto M; Shima H; Kato F
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):255-60. PubMed ID: 578071
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coagulation parameters in mother and newborn infant].
    Biland L; Duckert F
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1611-2. PubMed ID: 4645049
    [No Abstract]   [Full Text] [Related]  

  • 39. On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum.
    Binder B
    Thromb Diath Haemorrh; 1973 Nov; 30(2):280-3. PubMed ID: 4589772
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.